EDMONTON, ALBERTA--(CCNMatthews - April 28, 2006) - ViRexx Medical Corp. (TSX:VIR) (AMEX:REX), a company focused on immunotherapy treatments for certain cancers, chronic hepatitis B and C and embolotherapy treatments for tumors, announced today that the Company’s President, Marc Canton, was interviewed on April 27, 2006 by the Zangani Investor Community.
